Balloon inflation mechanically compresses plaque against the arterial wall, enlarging the passage available for blood flow. The procedure therefore acts directly on the physical obstruction rather than only managing its consequences pharmacologically. In cardiovascular care, that mechanical change can improve circulation through a narrowed or blocked coronary artery and help relieve ischemic symptoms.
A stent provides structural support after balloon treatment, helping the vessel remain open and maintain patency. A drug-eluting device adds a local pharmacological action: it releases medication at the treated site to limit tissue regrowth. This combines mechanical support with site-specific drug delivery, addressing both vessel openness and a biological response that could reduce it.
Antiplatelet therapy is used after angioplasty to help prevent clot formation. Its role differs from balloon inflation, which changes the narrowed vessel mechanically, and from drug-eluting devices, which release medication locally to limit tissue regrowth. This pharmacological component therefore addresses a clot-related threat to the treated vessel during post-procedure management.
During the angioplasty procedure, clinicians guide a catheter through the vascular system until it reaches the obstruction. They then inflate a small balloon to compress plaque against the arterial wall. A stent may be placed afterward to help maintain patency, with drug-eluting devices providing medication locally when used.
Angioplasty is especially relevant when impaired arterial circulation produces ischemic symptoms, and the coronary arteries are its most common treatment location. By restoring flow through the affected vessel, the intervention can relieve those symptoms and reduce complications associated with impaired circulation. This makes it an important intersection of cardiovascular intervention and pharmacological aftercare.
Pharmacology contributes at two points: drug-eluting devices release medication locally at the treated vessel, while antiplatelet therapy helps prevent clot formation afterward. These approaches do not replace the catheter and balloon's mechanical work. Instead, they complement it by addressing tissue regrowth at the treatment site and clot-related risk following the intervention.